US-guided Sciatic Nerve Block: Evaluation of the Intraneural Ropivacaine Minimal Effective Volume (MEV90)
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This prospective, double-blinded study evaluates intraneural ropivacaine 1% Minimal Effective
Volume (MEV90) for ultrasound-guided (US) popliteal sciatic nerve block, with Up-and-down
methodology.
To evaluate any neurological complications, an electrophysiological assessment will also be
performed preoperatively and at 5 weeks after surgery.